Aedo, V.
48  Ergebnisse:
Personensuche X
?
 
?
 
?
6

Response and Resistance to Trametinib in MAP2K1-Mutant Trip..:

Krebs, F.S ; Moura, B ; Missiaglia, E...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms24054520.  , 2023
 
?
7

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission..:

Bandiera, C ; Locatelli, I ; Courlet, P...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15010316.  , 2023
 
?
8

Development of an eHealth-enhanced model of care for the mo..:

da Silva Lopes, A.M ; Colomer-Lahiguera, S ; Darnac, C...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00520-023-07934-w.  , 2023
 
?
9

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequen..:

Aedo-Lopez, V ; Gérard, C.L ; Boughdad, S...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14051162.  , 2022
 
?
10

Estimated Costs of the Ipilimumab-Nivolumab Therapy and Rel..:

Gautron Moura, B ; Gerard, C.L ; Testart, N...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15010031.  , 2022
 
?
11

Patient-reported outcomes for monitoring symptomatic toxici..:

Da Silva Lopes, A.M ; Colomer-Lahiguera, S ; Mederos Alfonso, N...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2021.08.026.  , 2021
 
?
12

Real-life use of talimogene laherparepvec (T-VEC) in melano..:

Ressler, J.M ; Karasek, M ; Koch, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2020-001701.  , 2021
 
?
13

Oncologie [Advances in Oncology 2019]:

Vernadou, A ; Ferahta, N ; Mederos, N...
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.676-77.0072.  , 2020
 
?
14

Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48..:

Krebs, F.S ; Gérard, C ; Wicky, A...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms21218021.  , 2020
 
?
15

Oncologie [Advances in Oncology 2019]:

Vernadou, A ; Ferahta, N ; Mederos, N...
info:eu-repo/semantics/altIdentifier/pmid/31961089.  , 2020
 
1-15